The AAF1 returned for the non-specified prohibited substance Clostebol metabolite 4-chloro-3α-hydroxy-androst-4-en-17-one according to the Prohibited List of the World Anti-Doping Agency (WADA).
The sample was collected by the ITA under the testing authority and results management authority of the International Olympic Committee (IOC) during an in-competition anti-doping control on 18 February 2022 during the Pair Skating (short program). The result was reported by the WADA-accredited laboratory in Beijing on 21 February 2022.
The athlete has been informed of the case. She has the right to request the analysis of the B-sample.
The matter will thereafter be referred to the Anti-Doping Division of the Court of Arbitration for Sport (CAS ADD) for adjudication under the IOC Anti-Doping Rules applicable to the Olympic Games Beijing 2022 (IOC ADR).
Given that the case is underway, there will be no further comments during the ongoing proceeding.